News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
The safety and effectiveness of sacituzumab govitecan with trastuzumab for HER2+ Metastatic Breast Cancer
Breast Cancer
Jan 23, 2025, 02:32

The safety and effectiveness of sacituzumab govitecan with trastuzumab for HER2+ Metastatic Breast Cancer

Dana-Farber’s Breast Oncology Center shared on X:

“The SATEENtrial led by Dana-Farber’s Breast Oncology Center is a multi-center, single-arm phase II trial to evaluate the safety and effectiveness of sacituzumab govitecan with trastuzumab for HER2+ Metastatic Breast Cancer.
For more information call 877-338-7425 or visit.”

The safety and effectiveness of sacituzumab govitecan with trastuzumab for HER2+ Metastatic Breast Cancer

cancer Dana-Farber’s Breast Oncology Center OncoDaily Oncology
Special Coverage
Blog
May 11, 2025, 14:41
Honestly Spoken: Parenting and Metastatic Breast Cancer- ABC Global Alliance
Blog
May 11, 2025, 14:35
Christian Rolfo: ADC in Combination with Immunotherapy in NSCLC
Blog
May 11, 2025, 14:31
Ashwin Tamhankar Celebrates 201 Robotic Surgeries at Deenanath Mangeshkar Hospital Pune
Blog
May 11, 2025, 14:26
Ruben A. Mesa: Raising Funds to Support Atrium Health Wake Forest Baptist Comprehensive Cancer Center Patient Support program
Blog
May 11, 2025, 14:12
Laura Bukavina: General approach to Bladder Cancer in Heart and Kidney Transplant / ESRD Patients
Blog
May 11, 2025, 14:09
Kristina Jankovic: GI session and advanced HCC at NOK 2025 day 2
Blog
May 11, 2025, 14:07
Gerry Hanna: Ireland Should Consider Establishing a Parallel to NICE in Partnership with Other EU States
Blog
May 11, 2025, 14:04
Bruno Larvol Highlights Most Discussed Trials on X Using Larvol CLIN Platform
Blog
May 11, 2025, 13:58
Domenico Galetta: Interesting and Intense Discussion on the Role of Neoadjuvant vs Perioperative Chemo-Immunotherapy at RomeLung25
Science
May 11, 2025, 13:57
Giannis Mountzios: Shedding Light on Factors Influencing Treatment Sequence in BRAF Mutant NSCLC
Blog
May 11, 2025, 13:56
Alfonso Duenas Gonzalez: Quite odd, do not you believe?
Oncolibrary
May 11, 2025, 13:51
FDA Grants Accelerated Approval to Avutometinib and Defactinib for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer: RAMP 201 trial results